Novartis to acquire inflammasome-focused IFM Tre
Friday, April 5, 2019 - 06:20
in Mathematics & Economics
The big company is bolstering its portfolio with 3 NLRP3 antagonists
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via